Product Image

Contributor Information

  • Name Michelle Lockley
  • Institute Queen Mary University of London
  • Primary citation J I Hoare et al. 2022. Gynecol Oncol. 167(1):96-106. PMID: 35918200

Tool Details

  • Tool name: OvsahoCarbo cell line
  • Tool type: Cell Lines
  • Parental cell line: Ovsaho cell line
  • Organism: Mouse
  • Tissue: Ovary
  • Gender: Female
  • Cancer type: Gynaecologic cancer
  • Growth properties: Adherent
  • Model: Mutant
  • Model description: Platinum-resistant HGSC in vivo cell line
  • CRISPR: No
  • Description: Cells show increased expression of the ABCB1 drug efflux pump as well as reversion mutations in BRCA genes and loss of BRCA promoter-methylation. Platinum-resistant HGSC cancer cells with a growth advantage in the presence of therapy that expand to create drug-resistant tumours
  • Research area: Cancer
  • Production details: Cells were cultured in vitro in increasing concentrations of either cisplatin or carboplatin until an increase in IC50 between two and ten-fold was achieved to reflect the resistance observed in human patients

  • For Research Use Only

Target Details

Application Details


  • Growth medium: RPMI containing 10% FBS and 1% penicillin/streptomycin
  • Temperature: 37C
  • Cultured in antibiotics?: Streptomycin and Penicillin
  • STR profile: 16 locus STR verification (DNA Diagnostics Centre, London, UK: June 2015?February 2016 and European Collection of Authenticated Cell Lines August 2019)
  • Mycoplasma free: Yes



  •   J I Hoare et al. 2022. Gynecol Oncol. 167(1):96-106. PMID: 35918200